Case presentation
=================

In April 2001 a 71-year old male (German) was admitted to our hospital with unstable angina. Blood pressure at admission was 160/80 mmHg, LDL cholesterol was 127 mg/dl and no diabetes exist. The electrocardiogram showed persistent atrial fibrillation with negative T-waves in leads V~2~-V~5~. The angiography revealed 2-vessel disease with a 90% stenosis of the proximal LAD (Figure [1a](#F1){ref-type="fig"}). A bare-metal stent (3.0/18 mm) was implanted (Figure [1b](#F1){ref-type="fig"}). Aspirin und clopidogrel were prescribed against stent-thrombosis by the use of bare-metal stent for 4 weeks followed by oral anticoagulation with a vitamin-K antagonist (INR 2-3, phenprocoumon). Four years later the same patient was hospitalized once again with stable angina. Blood pressure was 130/70 mmHg at admission and in the meanwhile the patient had diabetes. The angiography showed a 80% instent-stenosis in the bare-metal stent but no progress at the other coronary arteries (Figure [2a](#F2){ref-type="fig"}). This time a sirolimus-eluting stent (CYPHER 3.0/23 mm) was implanted (Figure [2b](#F2){ref-type="fig"}). Aspirin, clopidogrel and the same oral anticoagulation (phenprocoumon) were given for three months against stent-thrombosis by use of drug-eluting stent followed by oral anticoagulation alone. Again, four years later, in February 2009, the patient presented with non-ST-elevation myocardial infarction. Blood pressure was 120/80 mmHg at admission and the patient presented with the same risk factors as prescribed. Angiography showed a 90% instent-restenosis in the LAD again without any progession of coronary artery disease in the other vessels (Figure [3a](#F3){ref-type="fig"}). Again, a drug-eluting stent (XIENCE V 3.0/28 mm) implanted (Figure [3b](#F3){ref-type="fig"}).

![**Angiography after implantation of a bare-metal stent (2001)**.](1757-1626-2-9407-1){#F1}

![**Second instent-stenosis in 2009**.](1757-1626-2-9407-2){#F2}

![**A. Second instent-stenosis in 2009**. b. Final result after PCI with drug-eluting stent in 2009.](1757-1626-2-9407-3){#F3}

Discussion
==========

This case is unusual, because a late instent-stenosis was observed twice without any difference in the time interval of the clinical occurrence of the restenosis between bare-metal and drug-eluting stent \[[@B1]-[@B3]\]. Usually restenosis occurs within 6 months after stent implantation. Thereafter the annual restenosis rate is only about 1-2%. In this case, the implantation of a DES did not prolong the time-interval until the restenosis became clinically apparent. Therefore, the processes involved in the late instent-stenosis in this patient were not influenced by the antiproliferative agent sirolimus \[[@B4],[@B5]\].
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